Solventum (SOLV) Competitors $73.67 +1.67 (+2.32%) As of 03:38 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock SOLV vs. GEHC, PHG, ZBH, SNN, PEN, STVN, GKOS, BLCO, IRTC, and TMDXShould you be buying Solventum stock or one of its competitors? The main competitors of Solventum include GE HealthCare Technologies (GEHC), Koninklijke Philips (PHG), Zimmer Biomet (ZBH), Smith & Nephew SNATS (SNN), Penumbra (PEN), Stevanato Group (STVN), Glaukos (GKOS), Bausch + Lomb (BLCO), iRhythm Technologies (IRTC), and TransMedics Group (TMDX). These companies are all part of the "medical equipment" industry. Solventum vs. Its Competitors GE HealthCare Technologies Koninklijke Philips Zimmer Biomet Smith & Nephew SNATS Penumbra Stevanato Group Glaukos Bausch + Lomb iRhythm Technologies TransMedics Group GE HealthCare Technologies (NASDAQ:GEHC) and Solventum (NYSE:SOLV) are both large-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, media sentiment, earnings, profitability, valuation, analyst recommendations, institutional ownership and risk. Does the media prefer GEHC or SOLV? In the previous week, Solventum had 1 more articles in the media than GE HealthCare Technologies. MarketBeat recorded 22 mentions for Solventum and 21 mentions for GE HealthCare Technologies. GE HealthCare Technologies' average media sentiment score of 1.46 beat Solventum's score of 1.13 indicating that GE HealthCare Technologies is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment GE HealthCare Technologies 20 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Solventum 13 Very Positive mention(s) 2 Positive mention(s) 7 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do institutionals and insiders believe in GEHC or SOLV? 82.1% of GE HealthCare Technologies shares are owned by institutional investors. 0.3% of GE HealthCare Technologies shares are owned by company insiders. Comparatively, 0.1% of Solventum shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. Which has better valuation and earnings, GEHC or SOLV? GE HealthCare Technologies has higher revenue and earnings than Solventum. GE HealthCare Technologies is trading at a lower price-to-earnings ratio than Solventum, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioGE HealthCare Technologies$19.67B1.75$1.99B$4.8815.41Solventum$8.39B1.52$478M$2.1634.10 Is GEHC or SOLV more profitable? GE HealthCare Technologies has a net margin of 11.22% compared to Solventum's net margin of 4.52%. Solventum's return on equity of 29.93% beat GE HealthCare Technologies' return on equity.Company Net Margins Return on Equity Return on Assets GE HealthCare Technologies11.22% 23.93% 6.29% Solventum 4.52%29.93%6.65% Which has more volatility & risk, GEHC or SOLV? GE HealthCare Technologies has a beta of 1.13, suggesting that its stock price is 13% more volatile than the S&P 500. Comparatively, Solventum has a beta of 0.52, suggesting that its stock price is 48% less volatile than the S&P 500. Do analysts recommend GEHC or SOLV? GE HealthCare Technologies presently has a consensus target price of $88.55, indicating a potential upside of 17.74%. Solventum has a consensus target price of $85.75, indicating a potential upside of 16.42%. Given GE HealthCare Technologies' stronger consensus rating and higher probable upside, analysts plainly believe GE HealthCare Technologies is more favorable than Solventum.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score GE HealthCare Technologies 0 Sell rating(s) 3 Hold rating(s) 8 Buy rating(s) 0 Strong Buy rating(s) 2.73Solventum 1 Sell rating(s) 6 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.27 SummaryGE HealthCare Technologies beats Solventum on 12 of the 16 factors compared between the two stocks. Get Solventum News Delivered to You Automatically Sign up to receive the latest news and ratings for SOLV and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SOLV and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SOLV vs. The Competition Export to ExcelMetricSolventumMedical Services IndustryMedical SectorNYSE ExchangeMarket Cap$12.77B$7.76B$5.81B$21.18BDividend YieldN/A2.64%3.84%3.59%P/E Ratio34.1179.8330.8929.13Price / Sales1.5230.16469.5354.97Price / Cash7.3324.8637.1523.84Price / Book3.5017.069.115.44Net Income$478M$243.33M$3.26B$992.10M7 Day Performance3.01%1.14%1.82%2.53%1 Month Performance0.98%0.85%4.81%2.44%1 Year Performance23.23%13.77%31.07%13.00% Solventum Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SOLVSolventum1.7725 of 5 stars$73.67+2.3%$85.75+16.4%+20.5%$12.77B$8.39B34.1122,000Positive NewsGEHCGE HealthCare Technologies3.6016 of 5 stars$73.17-0.3%$88.55+21.0%-13.4%$33.41B$19.67B14.9953,000Positive NewsShort Interest ↑PHGKoninklijke Philips4.0215 of 5 stars$27.47flatN/A-7.9%$26.45B$19.50B144.5866,678Positive NewsZBHZimmer Biomet4.7482 of 5 stars$102.67-0.1%$111.44+8.5%-6.9%$20.34B$7.68B24.9817,000Positive NewsSNNSmith & Nephew SNATS3.2215 of 5 stars$36.29+0.2%$36.00-0.8%+20.4%$15.89B$5.81B16.8017,349News CoveragePositive NewsPENPenumbra4.8205 of 5 stars$255.35+0.9%$300.47+17.7%+29.4%$9.96B$1.28B67.914,500Positive NewsSTVNStevanato Group1.8267 of 5 stars€22.50-0.5%N/A+18.6%€6.81B€1.19B41.675,521Gap DownGKOSGlaukos4.7654 of 5 stars$89.47-0.4%$127.42+42.4%-30.9%$5.13B$432.95M-54.22780Positive NewsBLCOBausch + Lomb2.2155 of 5 stars$14.49-0.4%$15.56+7.4%-10.1%$5.13B$4.79B-18.5713,500IRTCiRhythm Technologies1.5165 of 5 stars$157.93-1.7%$157.30-0.4%+135.9%$5.07B$591.84M-53.902,000News CoverageAnalyst ForecastTMDXTransMedics Group2.8744 of 5 stars$125.65-1.5%$123.00-2.1%-31.3%$4.28B$441.54M65.10210Positive News Related Companies and Tools Related Companies GEHC Alternatives PHG Alternatives ZBH Alternatives SNN Alternatives PEN Alternatives STVN Alternatives GKOS Alternatives BLCO Alternatives IRTC Alternatives TMDX Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:SOLV) was last updated on 8/22/2025 by MarketBeat.com Staff From Our PartnersSilver’s Still Under $35… For Now.Silver is trading around $33—but insiders are betting on a $70 breakout by year’s end. With supply shrinkin...GoldenCrest Metals | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAltucher: It Looks Like My Trump prediction is coming trueNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredBREAKING: The House just passed 3 pro-crypto bills!The “top secret” DeFi play Our #1 Coin Report reveals which protocol is building this institutional bridge...Crypto 101 Media | SponsoredTax Drain Deadline: Protect Your Wealth Before September 15thOn September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Solventum Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Solventum With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access